BCG-unresponsive high-grade non-muscle invasive bladder cancer: what does the practicing urologist need to know?

PURPOSE: Bacille Calmette-Guérin (BCG) is a well-established treatment for preventing or delaying tumour recurrence following high-grade nonmuscle invasive bladder cancer (NMIBC) resection. However, many patients will experience recurrence or progression during or following BCG. This scenario has be...

Descripción completa

Detalles Bibliográficos
Autores principales: Lebacle, Cedric, Loriot, Yohann, Irani, Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Topic Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997797/
https://www.ncbi.nlm.nih.gov/pubmed/33772322
http://dx.doi.org/10.1007/s00345-021-03666-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997797/
https://www.ncbi.nlm.nih.gov/pubmed/33772322
http://dx.doi.org/10.1007/s00345-021-03666-w

Ejemplares similares